Biogen Has Many `Exciting' Drugs in Pipeline: CEO

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Jan. 14 (Bloomberg) -- George Scangos, chief executive officer Biogen Idec Inc., talks about the company's multiple sclerosis drugs, pipeline and outlook. Scangos speaks with Erik Schatzker and Stephanie Ruhle on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change